Mary Thistle - 08 Aug 2024 Form 4 Insider Report for Cullinan Therapeutics, Inc. (CGEM)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CGEM	Stock Option (Right to Buy)	Award	$0	+25,743		$0.000000	25,743	08 Aug 2024	Common Stock	25,743	$16.38	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The option represents a right to purchase a total of 25,743 shares of the Issuer's common stock, which shall vest as to one-third of the shares underlying the option on each of the first, second and third anniversaries of the grant date of the award, subject to the Reporting Person's continued service as a director on each such vesting date.